ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
ENANTA PHARMACEUTICALS INC
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$11.41+0.31 (+2.79%)
Close on Oct 19, 2026
- Market cap
- $331.92M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Enanta Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 10, 2026 | Aug 10, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 2, 2026 | Jul 2, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2026 | Jun 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2026 | Jun 18, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 11, 2026 | May 11, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 20, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2026 | Mar 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2025 | Feb 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 9, 2026 | Feb 9, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 11, 2026 | Jan 26, 2026 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2025 | Nov 19, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 17, 2025 | Nov 17, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 30, 2025 | Oct 1, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 29, 2025 | Sep 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2025 | Aug 27, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2025 | Aug 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 13, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 12, 2025 | May 12, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 13, 2025 | Mar 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2024 | Feb 12, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 10, 2025 | Feb 10, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 13, 2025 | Jan 27, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2024 | Dec 9, 2024 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2024 | Nov 27, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 25, 2024 | Nov 25, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 5, 2024 | Aug 5, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 8, 2024 | SEC EDGAR |
| Current report | 8-K | May 6, 2024 | May 6, 2024 | SEC EDGAR |
| Current report | 8-K | Mar 6, 2024 | Mar 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Dec 31, 2023 | Feb 8, 2024 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2024 | Feb 7, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 6, 2024 | Jan 26, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2023 | Dec 26, 2023 | SEC EDGAR |
| Annual report | 10-K | Sep 30, 2023 | Nov 22, 2023 | SEC EDGAR |